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(57) ABSTRACT 
Methods and apparatus are provided for forming a vascular 
graft in vitro by axially distending a blood vessel to induce 
growth. The apparatus comprises a chamber containing a 
tissue culture medium, an inlet cannula, an outlet cannula, 
and a means for moving the inlet cannula, the outlet cannula, 
or both, to axially stretch a donor blood vessel secured 
between the inlet cannula and the outlet cannula in a 
submerged position in the tissue culture medium, wherein 
the inlet cannula, the outlet cannula, and the donor blood 
vessel are secured together to form a conduit through which 
the tissue culture medium can flow. 
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1 
DEVICE AND METHOD FOR CREATING A 
VASCULAR GRAFT IN VITRO 
2 
report of the American College of Cardiology/American 
Heart Association Task Force on Practice Guidelines", Com-
mittee to Revise the 1991 Guidelines for Coronary Artery 
Bypass Graft Surgery, American College of Cardiology/ CROSS-REFERENCE TO RELATED 
APPLICATIONS 5 American Heart Association, J. Am. Coll. Cardiol., 34( 4): 
1262-347 (1999)) strongly recommends a move to total 
arterial revascularization. This is a divisional of U.S. application Ser. No. 09/994, 
500, filed Nov. 27, 2001, now U.S. Pat. No. 6,641,576, 
which is a continuation-in-part of U.S. application Ser. No. 
09/322,095, filed May 28, 1999, now U.S. Pat. No. 6,322, 10 
553. Application Ser. No. 09/994,500 claims benefit of U.S. 
Provisional Application No. 60/274,702, filed Mar. 9, 2001, 
and application Ser. No. 09/322,095 claims benefit of U.S. 
Provisional Application No. 60/087,027, filed May 28, 1998. 
All of these applications are incorporated herein by refer- 15 
ence in their entirety. 
BACKGROUND OF THE INVENTION 
In some cases, autologous or homologous saphenous vein 
preserved by freezing or other processes is used. 
With people living longer, multiple surgeries are more 
common. At the same time, open-heart surgery is becoming 
routine, aided by the development of new, minimally inva-
sive and "off-pump" procedures that have dramatically 
simplified the surgery and reduced the recovery time. 
Development of a longer lasting small-diameter vascular 
graft is the subject of much academic and industrial 
research. One current approach is to combine cell culture 
and biomaterials technologies to make a living, "tissue 
engineered" graft. This effort, however, is hindered by the 
The present invention is generally in the area of methods 
and devices to obtain vascular tissue grafts and more spe-
cifically in the area of methods and devices to obtain grafts, 
preferably autologous grafts, prepared from living vascular 
tissue. 
20 requirements of a successful graft: It should be self-repair-
ing, non-immunogenic, non-toxic, and non-thrombogenic. 
The graft also should have a compliance comparable to the 
artery being repaired, be easily sutured by a surgeon, and not 
require any special techniques or handling procedures. 
25 Grafts having these characteristics are difficult to achieve. Vascular grafts are commonly used by surgeons to bypass 
obstructions to blood flow caused by the presence of ath-
erosclerotic plaques. Vascular grafts also are used in other 
applications such as providing arterial-venous shunts in 
dialysis patients, vascular repair or replacement and treating 
aneurysms. Grafts for bypass are often, but not exclusively, 30 
used in the coronary arteries, the arteries that supply blood 
Despite the substantial effort to date and the potential for 
significant financial reward, academic and industrial inves-
tigators have failed to produce graft materials that have 
demonstrated efficacy in human testing. 
Efforts to avoid or minimize the need for vascular grafts 
for repair of otherwise healthy vascular tissue have been 
described. For example, Ruiz-Razura et al., J. Reconstruc-
tive Microsurgery, 10(6):367-373 (1994) and Stark et al., 
Plastic & Reconstructive Surgery, 80( 4):570--578 (1987) 
to the heart. The materials used to construct a vascular graft 
usually are either synthetic or of biological origin, but 
combinations of synthetic and biological materials are under 
development. The most widely used biological vascular 
grafts are autologous saphenous vein or mammary artery. 
Some common synthetic grafts are made of polytetrafluo-
roethylene (PTFE) (e.g., GORTEX™) or polyester (e.g., 
DACRON™). Autologous grafts have generally been used 
more successfully than synthetic grafts. Autologous grafts 
remain patent (functional) much longer than synthetic grafts, 
and saphenous veins often fail in less than five years. The 
short lifetime of synthetic grafts is especially evident with 
small diameter (less than 7 mm diameter) grafts, as most 
small diameter synthetic grafts occlude within one to two 
years or less. 
35 disclose the use of a round microvascular tissue expander for 
acute arterial elongation to examine the effects on the tissue 
of such acute hyperextension. The expander is a silicone 
balloon that is placed under the vessel to be elongated. The 
balloon is filled with saline over a very short period, causing 
40 acute stretching and elongation of the vessel. The method is 
purported to be effective for closure of arterial defects up to 
30 mm without the need for a vein graft. These techniques 
are appropriate for trauma, but are not used for restoring 
blood flow in vessels that are occluded, for example by 
45 disease, which are treated by surgically bypassing the 
obstruction with a graft. The disclosed methods and devices 
fail to provide an autologous graft or versatile substitute. 
Moreover, the acute stretching may damage the vessel. 
Small diameter vascular grafts are particularly used in 
coronary artery bypass surgery. Internal mammary artery 
(IMA) is the autologous graft of choice, because it typically 
has a longer life than venous grafts (95% patent at 5 years 
versus 85% patent at 2 years). Mammary arterial tissue, 
however, is difficult to harvest, typically is not available in 
lengths sufficient for multiple bypasses, and its removal can 
result in problems such as problematic wound healing. 
Moreover, obtaining sufficient venous tissue for repairing an 55 
occluded artery can be problematic in patients with venous 
conditions such as varicose veins and especially in second or 
third surgeries in the same patient. Recent literature also 
suggests that IMA used in bypass procedures either fails 
soon after transplantation or remains patent indefinitely. See, 60 
e.g., Bergsma, et al., Circulation 97(24):2402--05 (1998); 
Cooley, Circulation 97(24):2384-85 (1998). Other arteries 
such as the gastroepipolic, gastric, radial, and splenic also 
It is therefore an object of the present invention to provide 
50 devices and methods for creating natural blood vessel suit-
able for grafting. 
are used in coronary bypass procedures. Moreover, the 
recent American Heart Association/American College of 65 
Cardiology consensus document (Eagle, K. A, et al. "ACC/ 
AHA Guidelines for coronary artery bypass graft surgery: A 
It is another object of the present invention to provide 
devices and methods for making an autologous blood vessel 
graft. 
It is further object of the present invention to provide 
devices and methods for creating blood vessel grafts in vivo 
or in vitro. 
These and other objects, features, and advantages of the 
present invention will become apparent upon review of the 
following detailed description of the invention taken in 
conjunction with the drawings and the appended claims. 
SUMMARY OF THE INVENTION 
Devices and methods are provided for forming a vascular 
graft by axially distending a blood vessel to stimulate vessel 
growth. Preferably, the device is implanted, for example 
US 6,991,628 B2 
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culture growth medium. In operation, a donor blood vessel 
is secured by having a first end of the vessel secured to the 
second end of the inlet cannula and a second end of the 
using endoscopic techniques, for use in vivo. A portion of a 
blood vessel (i.e. the donor vessel) then is distended using 
the device. Preferred donor vessels include the gastroepi-
polic artery, as well as the internal mammary, femoral, 
gastric, splenic, and radial arteries. Then, the in vivo dis-
tended portion of the donor vessel is excised, for example, 
at the time of by-pass surgery. In an alternative embodiment, 
vessel secured to the second end of the outlet cannula, 
5 thereby forming a conduit through the blood vessel and 
between the first end of the inlet cannula and the first end of 
a section of donor vessel is surgically excised from the 
bypass surgery patient, preferably at the time of by-pass 
surgery, and then distended in vitro in a medium for cell 10 
growth, e.g., in an organ culture system or bioreactor. Where 
the donor is the recipient of the graft, the result using either 
approach advantageously is a totally autologous, living 
vascular graft. 
In a preferred embodiment, the device comprises a 15 
stretching mechanism which includes (i) a stabilization rod, 
(ii) a pair of rotatable elements, wherein each rotatable 
element is rotatably attached to the elongated body and has 
the outlet cannula. Preferably, tissue culture growth medium 
flows through this conduit. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a plan view of one embodiment of the device for 
vessel distension. 
FIG. 2 is a plan view of a second preferred embodiment 
of the device for vessel distension. 
FIG. 3 is a side elevational view of the distension device 
shown attached to a donor blood vessel. 
FIGS. 4A and 4B are illustrations of a normal and 
stretched blood vessel. 
FIGS. SA-C are front (SA), plan (SB), and side (SC) 
views of one embodiment of the device for vessel distension 
using fixed points of vessel attachment. 
a channel substantially perpendicular to the axis of rotation, 
and (iii) a means for rotating each rotatable element to 20 
axially distend a blood vessel positioned in the channels of 
the rotatable elements. The elements can be rotated inter-
mittently, cyclically, or continuously, over a period to dis-
tend or elongate the donor vessel. 
FIGS. 6A-C are diagrams showing vessel distension 
using a preferred embodiment of the device having points of 
25 vessel attachment that are fixed relative to one another. The rotatable elements can, in one embodiment, comprise 
a pair of arms extending from a central base, the arms being 
capable of bending or flexing between a straight configura-
tion and a curved configuration. The straight configuration 
preferably is used to give the device a narrow profile suitable 
FIGS. 7A-C are front (7A), plan (7B), and side (7C) 
views of one embodiment of a device for both rectilinear and 
curvilinear vessel distension. 
FIGS. 8A-B are diagrams showing vessel distension 
using one embodiment of the device for both rectilinear and 
curvilinear vessel distension. 
FIG. 9 illustrates a passive power source adaptable to 
powering the stretching device shown in FIG. 1. 
for endoscopic insertion into a donor patient. The arms can 30 
have an inherent spring action, such that the relaxed state of 
the arms is a curved configuration and wherein the arms will 
transform from the straight configuration into a curved 
configuration upon release of one or more releasable fas-
teners. 35 
FIG. 10 illustrates an organ culture or bioreactor system 
modified to allow axial extension of a blood vessel con-
In another variation, the rotatable elements each comprise 
a pair of rounded lobes extending from a central base, the 
channel extending between each pair of lobes. The lobes can 
comprise a disk-shaped portion having an outer edge surface 
distal the axis of rotation of the rotatable element and a 40 
substantially fiat upper surface distal the stabilization rod. 
The outer edge surface can include one or more grooves in 
which a blood vessel or portion thereof can be positioned, 
supported and guided during the stretching process. 
The means for rotating can comprise a torsion spring and 45 
a cam mechanism for controlling the rotation position, 
and/or a prime mover that is mechanically, electromechani-
cally, or hydraulically driven. 
tained therein to induce growth. 
FIGS. llA-E are plan views of a preferred embodiment 
of a device employing a pair of rotatable elements that 
provide both rectilinear and curvilinear vessel distension. 
FIGS. 12A-F are plan views (FIGS. 12A-B, 12D-F) and 
a side view (FIG. 12C) of another preferred embodiment of 
a device employing a pair of rotatable elements which 
provide both rectilinear and curvilinear vessel distension. 
FIGS. 13A-E are plan views (FIGS. 13A-D) and a side 
view (FIG. 13E) of another preferred embodiment of a 
device employing a pair of rotatable elements which provide 
both rectilinear and curvilinear vessel distension. 
The device optionally can include a growth factor or other 
growth stimulating agent for release in an effective amount 
to enhance growth of the blood vessel. Such agents may be 
impregnated into the materials of construction forming the 
device or can be in the form of a coating or a reservoir device 
attached to the stretching device. 
FIG. 14 is a side view of a variation of a preferred device, 
50 wherein the rotatable element includes multiple grooves for 
guiding a blood vessel during the rotating and stretching 
Also provided is an apparatus for extending a donor blood 55 
vessel of a human or animal in vitro. The apparatus includes 
a chamber containing a quantity of tissue culture growth 
medium; an inlet cannula extending through a first orifice in 
the chamber, the inlet cannula having a first end outside of 
the chamber and a second end positioned inside the cham- 60 
ber; an outlet cannula extending through a second orifice in 
the chamber, the outlet cannula having a first end outside of 
the chamber and a second end positioned inside the cham-
ber; and a means, such as a linear motor, for moving the inlet 
cannula, the outlet cannula, or both, to axially stretch a 65 
donor blood vessel secured between the inlet cannula and 
the outlet cannula in a submerged position in the tissue 
process. 
DETAILED DESCRIPTION OF THE 
INVENTION 
It is known that smooth muscle cells, which dominate the 
media, the major load bearing layer of the arterial wall, 
proliferate and increase their production of extracellular 
matrix in response to mechanical stimulation. It was dis-
covered that this knowledge could be advantageously 
applied to create an autologous graft of appropriate diameter 
for coronary bypass or other vascular graft application using 
a distension device to stimulate angiogenesis. While an 
autologous graft is preferred, the devices and methods 
described herein also can be applied to an artery from 
another human or other animal, including transgenic animals 
US 6,991,628 B2 
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genetically engineered to have tissues that will not be 
rejected by humans. The distension device can be adapted to 
operate in vivo or in vitro. 
The devices and methods described herein can used to 
6 
known in the art. Alternatively, the prime mover can operate 
hydraulically. An active device generally requires input over 
time. The prime mover also can be a passive device such as 
make allogeneic and xenogeneic vascular grafts, as well as 5 
the more preferred autogeneic vascular grafts. 
a spring or a combination of a spring and a damper, where 
stored mechanical energy is used to push and/or pull the 
straps away from each other. 
Distension Device 
The distension device secures the donor blood vessel at 
different points on the vessel and then distends or stretches 
the vessel between those points to form an elongated por-
tion. The elongated portion can then be excised for use as a 
vascular graft. Stretching can be continuous, cyclical, or 
intermittent, and can occur rectilinearly, curvilinearly, or in 
a combination thereof. The stretching can occur between 
vessel attachment points that are movable relative to one 
other or in fixed positions relative to one other. 
I. Movable Attachment Positions 
Linear or rotary piezo micro-motor devices (actuators) 
deliver small step sizes, small forces, have relatively simple 
control electronics and inherent force overload protection. 
10 Suitable devices are available from a number of vendors, 
including Micro Pulse Systems, Inc. Parameters of the 
operating means include the force applied by the stretching 
mechanism, the rate and direction of movement of the 
stretching mechanism, the length of time that the stretching 
15 mechanism is operated, and the type of stretching applied 
(e.g., continuous, cyclical, or intermittent). 
C. Controller 
The device typically includes a stretching mechanism that 
can be attached by means such as straps or sutures to the 20 
donor blood vessel, a means for operating the stretching 
mechanism to cause the vessel to distend (i.e. extend), and 
The controller controls the operating means. In the in vivo 
distension embodiments, the controller can include a micro-
processor that is implanted and that can be activated, pro-
grammed, or reprogrammed by an externally applied mag-
netic or electromagnetic field. The controller also can be 
a controller for controlling the operating means. 
A Stretching Mechanism 
In a preferred embodiment, the distension device stretch-
ing mechanism includes a pair of opposed straps or loops 
that are fixedly attached to the donor blood vessel such as by 
sutures. The opposed straps are displaced away from each 
other over a period of time so that the donor vessel elongates 
as the straps are displaced. After a period of time, such as 
when the straps are displaced a pre-determined distance, the 
section of vessel and the device are removed and the ends of 
the donor vessel are sutured together if needed. 
The device straps should be made out of a biocompatible 
material such as a synthetic or natural polymer or metal. The 
straps must be able to be attached to the vessel, for example, 
using sutures, staples, or adhesion. Examples of suitable 
material for the straps are polytetrafiuoroethylene (PTFE), 
polyester (e.g., DACRON™), nylon (e.g., DELRIN™), 
polysulfone, polypropylene, and polyethylene. The strap 
material preferably is doped to render it radio opaque, so that 
the stretching process can be monitored using x-ray tech-
niques. The straps can be wrapped in a material that is then 
attached to the vessel, or they can include perforations or 
holes to accommodate suturing to the vessel. The straps 
preferably have a flex strength to support the distending 
force applied on the stretching mechanism. 
The device includes a means to displace the straps away 
from each other and stretch the vessel. This displacement 
can be accomplished by any of a variety of techniques. For 
example, the device can include rods attached to the straps 
that can be moved to push or pull on the straps to slowly 
displace the straps from each other. The rods can be moved, 
for example, by mechanical or hydraulic means. 
B. Operating Means 
25 activated, programmed, or reprogrammed externally using 
wires that pass through the skin, or by wireless means for 
transmitting power or data known in the art wherein wires 
need not pass through the skin. 
One embodiment of the device is shown in FIG. 1. 
30 Proximal locking strap 10 and distal locking strap 12 are of 
adjustable length appropriate for a secure fit around the 
donor blood vessel to be distended. Blood vessels range 
from about 0.2 to 2 cm in diameter. The locking straps 10, 
12, include a lace 14, 16, respectively, of a biocompatible 
35 material, such as DACRON™, that can be secured to the 
donor vessel, such as by suturing, stapling, or using an 
adhesive agent. In a preferred embodiment, the laces are 
designed similarly to the sewing rings of a standard artificial 
heart valve. Alternatively, a layer of a material, such as a 
40 fabric or film, can be attached to the strap so that the vessel 
can be sutured, stapled, or adhered to the material to hold the 
strap to the vessel. In another embodiment, the strap 
includes perforations, holes, or other structural features 
amenable to suturing or stapling, so that the vessel can be 
45 sutured or stapled directly to the strap. The locking straps 
each have a head 11, 13 with an internal aperture. Preferably, 
the straps 10, 12 include a plurality of teeth (not shown) that, 
when the free end of the lace 14, 16 is inserted through the 
aperture of the head of the strap, it engages the head and 
50 prevents the free end of the lace from becoming disengaged, 
in a manner similar to that of standard pull-ties. Alterna-
tively, the head of the strap can engage the strap if the lace 
14, 16 does not cover the entire strap or if the strap includes 
securing holes or perforations as described above. The straps 
55 optionally may be impregnated or coated with one or more 
growth stimulating agents (e.g., growth factors) that can be 
released in an effective amount to promote vessel tissue 
growth during the stretching procedure. 
Sliding bearings 18, 20, on straps 10, 12, respectively, and 
60 stops 22 and 24, respectively, can be either attached to or 
integrally formed (during manufacture) with the straps or 
laces as shown. The bearings and stops are preferably made 
of the same material as the straps, although other biocom-
The device includes means to operate the stretching 
mechanism, preferably including a prime mover and elec-
tronic drivers for the prime mover, both of which are 
preferably implanted. The prime mover can be an electro-
mechanical (active) device, such as a linear-motor that 
operates the stretching mechanism to push and/or pull the 65 
straps away from each other. A rotary motor could also be 
used to generate the required linear motion, using techniques 
patible materials can be used. 
A first push/pull rod 26 is fixedly attached to proximal tie 
strap 10 at stop 22. A second push/pull rod 28 is fixedly 
attached to distal tie strap 12 at stop 24. The two push/pull 
US 6,991,628 B2 
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rods are preferably initially not fitted to the locking straps 
but are easily assembled on the device in vivo after the 
locking straps are 30 secured around the vessel and sutured 
8 
cable 36 in the embodiment shown in FIG. 1. The first orifice 
184 can be of a fixed size or a variable size to control the 
movement of the piston 188. For example, orifices made of 
or otherwise fixed in place. The push/pull rods slide through 
the bearings 18, 20 and engage the stops 22, 24. The 5 
proximal locking strap 10 including the lace 14, sliding 
bearing 18, stop 22, and the fixedly attached rod 26 form a 
first integrated stretch unit 30. The distal locking strap 12 
including the lace 16, sliding bearing 20, stop 24, and the 
fixedly attached rod 28 form a second integrated stretch unit 10 
32. Push/pull rods 26, 28 are preferably made of a rigid 
material such as stainless steel, titanium or a biocompatible, 
rigid plastic. 
piezoelectric or magnetostrictive materials can be made to 
selectively vary in size by the application of an appropriate 
electric or magnetic field. The spring 190 can have a linear, 
nonlinear or constant force deflection characteristic and may 
consist of multiple springs acting together and designed to 
produce the required stretching force and motion profile. 
Those skilled in the art will recognize that this device can be 
adapted to either push or pull on the cable or wire, depending 
on the arrangement of the elements. 
FIG. 2 illustrates a second embodiment 70 of a device for 
vessel distension. The hydraulic embodiment uses two min-
iature, double-acting hydraulic cylinders 72, for example 
made of stainless steel, titanium or polymer, through which 
hydraulic force is exerted to stretch the blood vessel by 
pushing on straps 10. Double acting hydraulic cylinders 72 
A wire (or cable) 36, preferably stainless steel or titanium, 
is fixedly attached to first push/pull rod 26 at 38 and passes 15 
freely through a hole 40 in push/pull rod 28. The wire 36 
then passes freely through the sheath 44 into the prime 
mover housing 46. The prime mover shown is a piezo-
actuator or other linear motor. Those skilled in the art will 
recognize that several suitable means for pulling the wire or 
cable are known. For example, the wire or cable can be 
pulled by a hydraulic cylinder or actuator powered by an 
implanted pump or by transcutaneous injection of a fluid, 
such as saline. The wire or cable also could be wound on a 
rotating reel or attached to a lead screw configured to 
produce linear motion, wherein either is powered by electric 
20 are connected by a hydraulic line 74 into which fluid flows 
from the housing 76 which comprise a reservoir of a fluid 77 
such as saline. Pressure is generated by a piston 78 driven by 
threaded rod 80, positioned on a rod support 81, pushing the 
saline from the reservoir out at 83. Alternatively, pressure 
25 may also be generated by means external to the body using 
a catheter through the skin or by injection into an implanted, 
subcutaneous port. Such ports are commonly available. The 
threaded rod 80 is driven using torque generated by fric-
or hydraulic rotary actuators. FIGS. 1 and 2 show two 
opposing piezo-actuators 50 contained in the housing 46 
which can be activated to provide micron-sized step 
advancement of the driven element 52. Wire 36 is attached 
to driven element 52 by a hook 54 or other means so that 
wire 36 is advanced along with driven element 52. Micro 
Pulse Systems, Inc. makes micro-actuators that are suitable 
for the device disclosed herein. 
As the actuator 48 pulls the wire 36, the first integrated 
stretch unit 30 is pushed/pulled towards the actuator 48, in 
the direction of arrow 53. The locking straps are thus 
displaced away from each other. 
30 tional engagement with piezo-actuators 82 or by a miniature 
permanent magnet or other suitable motor. Micro Pulse 
Systems Inc. supplies piezo-actuators suitable for use in the 
device. Driver electronics and a power source are indicated 
by 84. Note that while FIG. 2 shows a hydraulic mechanism 
35 
wherein only strap 10 is moved, the hydraulic system may 
be readily adapted by one of skill in the art to exert force on 
both strap 10 and strap 12. 
The device preferably includes an external driver and 
controller, which are not shown in the Figures. In a preferred 40 
embodiment, the wire can be activated from outside the 
body once the wire is passed through the skin. Mechanisms 
outside the body are easier to design and transcutaneous 
catheters and similar conduits are highly developed. 
Alternatively, one skilled in the art could adapt the spring 
driven piston system illustrated in FIG. 9 to provide hydrau-
lic power to the embodiment illustrated in FIG. 2. 
The mechanical or hydraulic stretching mechanism works 
to move the straps apart slowly over a period of up to several 
weeks. In one embodiment, the passive driver element 
illustrated in FIG. 9 may be used to provide a pre-deter-
mined stretch over time. In another embodiment, the driver 
may be pre-programmed to operate autonomously, or the 
A particularly simple passive device for producing the 45 
linear motion needed to pull the wire 36 is illustrated in FIG. 
9. The device 180 includes a cylinder 182 having a first 
orifice 184 at one end 181 and a second orifice 186 at the 
other end 183, and containing a movable piston 188, a 
compression spring 190, and working fluid 192. Adjacent 
the one end 181 is an extension 185 of the cylinder 182, 
which contains an absorbent material 194 and includes a 
vent hole 196. The sheath 44 of wire 36 enters the cylinder 
through second orifice 186, and the wire 36 is attached to the 
piston 188 at its center 198. The spring 190, which typically 
is made of stainless steel, titanium or titanium alloy, par-
ticularly nickel-titanium, is in compression and pushes pis-
ton 188 toward first orifice 184, thereby forcing the fluid 
192, typically a biocompatible saline solution, through first 
orifice 184, where it is absorbed by the absorbent material 
194. Representative examples of absorbent materials include 
synthetic hydrophilic substances, such as certain polymers, 
or natural materials, such as cellulose. Air or other gas in the 
interstices of the highly absorbent material 194 that is 
displaced by the fluid 192 exits from the piston through vent 
196. It can be seen that the piston movement provides a 
continuous driving force and linear motion to the wire or 
driver may be programmed (or reprogrammed) following 
implantation by transcutaneous electromagnetic means, 
based, for example, on x-ray data or other indications of how 
50 the process is proceeding. The driver may be simply turned 
on or off, or may be programmed or reprogrammed by a 
magnetic field sensing device such as a reed switch (relay) 
or by other electronic devices or circuits responsive to 
magnetic or electromagnetic fields. The field is generated by 
55 using the external driver control to periodically activate an 
external source positioned to activate the electronic driver 
circuit. The external driver control may be pre-programmed 
to provide a stretch of several centimeters over about one 
month. Alternatively, cyclic stretching of increasing peak 
60 and mean amplitude may be used. Using piezo actuators, 
activating the driver can produce incremental movements of 
the mechanical or hydraulic stretching mechanism as small 
as a few microns. The prime mover is designed to be force 
limited to preclude overstretching the vessel. Force limita-
65 tion is inherent if the piezoelectric actuators are used in 
either embodiment and, in the case of permanent magnetic 
motors, can be designed into the electronic driver circuit. 
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II. Fixed Attachment Positions 
10 
that exposure to body fluids or another appropriate stimulus 
causes the material to expand and fill the area between 
plates. 
III. Combination Fixed/Movable Attachment Positions 
Other embodiments combine rectilinear and curvilinear 
stretching. One such embodiment is a slightly modified 
version of device 90 (shown in FIGS. 5A-C) and is illus-
trated in FIGS. 7A-C. The device 150 includes strip 152, 
that is formed much like strip 94, except that it is formed in 
In stretching an artery to stimulate angiogenesis, the 
blood vessel portion that is beyond the region where the 
stretching apparatus is attached will be relaxed from its 
normal stretched state and could possibly be relaxed to the 5 
point where it is put in compression, as illustrated in the 
FIGS. 4A and 4B. FIG. 4A illustrates a blood vessel as it is 
normally stretched in vivo, and FIG. 4B illustrates how a 
stretching device having points of contact (X) between 
vessel sections A and B and between A and C. The stretching 
device elongates section A while relaxing sections B and C. 
The consequences of this are unknown, but can be avoided 
10 a slightly curved or angled configuration and includes at 
least one, and preferably several, plates (or tabs) 154, 
positioned at or near the long edge of the strip 152 so as to 
form a channel 156. Strip 152 has flexible ends 158 for 
attachment to the blood vessel. A blood vessel is placed in if the blood vessel is stretched between two fixed points, as 
described herein. 
One embodiment of the fixed-point device is shown in 
FIGS. 5A-C. The device 90 includes two semicircular or 
similarly shaped thin, yet rigid, plates 92 made of or 
completely covered by a biocompatible material, such as 
stainless steel, titanium, titanium alloy, fiber composite, or 
polymer. The plates are separated and connected so as to 
remain parallel by a fiat rectangular strip of similar material 
94. The ends of the strip 96 are perforated or otherwise 
formed to accept surgical sutures or other means (e.g., 
15 channel 156 and attached to the strip 152, like described for 
strip 94, wherein plates 154 serve to hold the blood vessel 
in place. The space between the plates contains one or more 
(three are shown) inflatable balloons 160, which are like 
balloon 100 described above. Inflation of the balloon(s) can 
20 be accomplished using at least one access port 162, also as 
described above. 
25 
adhesive) known in the art to secure a blood vessel to the 
strip at its ends. The ends 96 are also flexible and easily bent, 
but without breaking, about axis 98 shown. The device can 
be formed from a single appropriately shaped thin plate. The 
area between the plates contains at least one inflatable 30 
balloon 100, which may be formed from silicone, rubber, 
elastomeric polymers, or any other highly deformable bio-
compatible material. As the balloon 100 is inflated, it fills the 
space between the two thin plates 92 without significantly 
changing the spacing between the two plates 92, since the 35 
plates 92 and strip 94 are sufficiently rigid to ensure this. 
Inflation of the balloon 100 can be accomplished using at 
least one access port 102, through which a fluid, such as 
saline, is injected, for example, through a needle or catheter 
connected to a syringe or similarly functioning device. The 40 
inflation process can occur through the skin. The balloon is 
designed and attached to the strip in such a manner that, at 
full inflation, it assumes more or less the shape of the space 
between the two plates confining it. 
Method for Distending a Blood Vessel 
The distension device can be adapted to operate in vivo or 
in vitro, that is to distend a portion of a blood vessel in vivo 
or following its excision from the body and subsequent 
placement in a medium for cell growth. As used herein, the 
phrase "medium for cell growth" includes any in vitro 
system for facilitating cell division, extra-cellular matrix 
formation, and growth of vessel tissue. For example, the 
distension device can be attached to an excised portion of 
donor vessel and submerged in a medium for cell growth in 
a temperature-controlled container. As described in Example 
1, it has been shown that distension in an organ culture (e.g., 
a bioreactor) significantly stimulates cell division, and can 
be simple to control. See, for example, U.S. Pat. No. 
5,899,936 to Goldstein; U.S. Pat. No.5,879,875, to Wiggins, 
et al.; and U.S. Pat. No. 5,888,720 to Mitrani, which describe 
techniques for organ and tissue culture which can be adapted 
to the methods described herein. 
I. Operating the Movable Positions Device 
The method for distending a donor blood vessel can 
include attaching a stretching mechanism to the donor vessel 
and operating the stretching mechanism to stretch the donor 
An alternative stretching mechanism is provided by 
hydrophilic or chemically reactive synthetic substances 
(e.g., various polymers) or other natural materials (e.g., 
cellulose) known to significantly expand their dry volume 
when activated as by exposure to fluid or possibly other 
stimuli (e.g., heat, radiation or various chemical agents). 
Such materials are available in foamed, fiber or other forms, 
any of which may be adapted by one of skill in the art to 
effect the balloon inflation described herein. One or more of 
45 vessel. In one embodiment, the method involves using a 
device wherein a pair of straps are fixedly attached to the 
donor vessel and moved away from one another so that the 
portion of the vessel between the straps is distended. The 
distended portion can then be excised and used as a graft. 
50 Grafts for coronary by-pass surgery are typically between 
about 10 cm and 15 cm in length, whereas grafts for by-pass 
in the peripheral circulation are typically about 25 cm or 
more in length. Those of skill in the art can readily optimize 
the rate of vessel distension. Distension rates can be linear these materials can be placed inside the balloon and 
expanded by the controlled addition of a fluid or chemical 55 
agent, such as by injection into the balloon, which causes the 
materials to expand, inflating the balloon, in much the same 
way as simply pumping saline or another fluid into the 
balloon as described above. The material could also be 
otherwise encapsulated or separated from the stimuli to 
control its means and rate of activation. For example, 
expandable material could be provided with a degradable 
coating or other timed-release mechanism, and such mecha-
nisms can be readily adapted from those used in controlled 
drug delivery. Alternatively, the balloon can be omitted, and 
the hydrophilic or other volume expanding material can 
simply be placed between the two plates in such a manner 
or nonlinear, and may average, for example, between about 
5 and 10 mm/day. 
One embodiment of the method is illustrated in FIG. 3, 
wherein a device (e.g., the one shown in FIG. 1) is attached 
to a donor blood vessel 60. The device can be assembled 
60 before or at the time of implantation. Straps 10, 12 are 
engaged to encircle the donor vessel and are then sutured in 
place. Push/pull rods 30, 32 are attached to the straps. Wire 
36, and the housing assembly shaft 44, and housing 46 
(containing the actuator) are attached to the device. Prefer-
65 ably, the active prime mover is implanted complete with its 
drive circuit and a minimal power source. Alternatively, a 
passive device, such as described above, can be used. As 
US 6,991,628 B2 
11 
either device is operated, the section of vessel 60 between 
the straps 10, 12, indicated by 62, stretches. 
12 
Stretched blood vessels can be effectively preserved for 
bypass surgery, for example, using known cryogenic or 
freeze-drying techniques. II. Operating the Fixed Positions Device 
FIG. 10 illustrates an organ culture or bioreactor system 
5 200 modified to accommodate the need to stretch a blood The device using fixed attachment positions is preferably 
operated as shown in FIGS. 6A-C, which show a cross-
sectional view (a-a) of the device in FIGS. 5A-C, at 
increasing degrees of vessel distention occurring with 
increasing inflation/expansion of the balloon/expanding 
material. In operation, the target blood vessel 93 is placed 10 
between the two plates 92, resting on the uninflated balloon 
100 (or unexpanded material) and secured to the flexible 
ends 96 of the strip 94, for example by sutures or other 
suitable means (FIG. 6A). As the balloon is inflated (or the 
material expanded), the blood vessel 93 is stretched (FIG. 15 
6B), between the two fixed ends 96 and continues to stretch 
vessel to induce growth. A donor blood vessel 202 is 
connected at its two ends to first and second cannulas 20S 
and 210 so that it is continuously immersed in a suitable 
tissue culture medium 206 at physiological temperature. A 
representative example of a tissue culture medium consists 
of DMEM (Sigma D1152), sodium bicarbonate (3.7 g/L, 
Sigma), L-glutamine (2 mM, Sigma), antibiotic-antimycotic 
solution (10 ml/L, Gibco), calf serum (CS 10%, Integren) 
and, possibly, Dextran (5% by weight, MW 282,000 Sigma). 
The medium 206 is contained a liquid-tight chamber 204, 
having gas inlet aperture 212 and gas outlet aperture 214, to 
permit gases, such as a mixture including oxygen and carbon 
dioxide, to enter the chamber 204, exchange gases with the 
medium 206, and then exit the chamber 204. The chamber 
as the space between the two plates is filled (FIG. 6C), 
without the possibility of reducing the tension in or com-
pressing the blood vessel 93 not between the points of 
attachment. 
III. Operating the Combination Fixed/Movable Positions 
Device 
20 204 may also include one or more openings (not shown) to 
permit changing or replenishing of the medium 206. Second 
cannula 210 is generally fixed and passes into the chamber 
204 through seal 216, whereas first cannula 20S passes The device using the combination of fixed and movable 
attachment positions is preferably operated as shown in 
FIGS. SA-B. FIG. SA shows a blood vessel attached to the 25 
device before application of the bending force (i.e. before 
distension). FIG. SB shows the device and blood vessel 
following application of the bending force, wherein strip end 
through a sliding seal 21S and can move linearly to effec-
tively stretch or relax the blood vessel 201. The linear 
motion of the cannula or the force exerted on the blood 
vessel can be controlled by a linear motor or by means such 
as described herein. Tissue culture medium, at physiological 
temperature and pressure (including pulsatility), preferably A is drawn towards strip end B. The device can be, for 
example, device 150 described above. 30 is continuously introduced into cannula inlet 220, flows 
through blood vessel 202, and then exits from cannula outlet 
222. This internal medium also should be exposed to carbon 
dioxide and oxygen gases so that gas exchange can occur. 
In operation, the target blood vessel 153 is first placed in 
the channel formed by plates 154, resting on the uninflated 
balloon 160 and secured to the flexible ends 15S of the strip 
152, for example by sutures or other suitable means. The 
ends 15S of the strip 152 are then drawn towards each other 35 
by mechanical or other forces to cause strip 152 to bend or 
flex, thereby stretching the blood vessel 153. The ends can 
be drawn towards one another by any suitable means, 
including a mechanical or magnetic force, or by a differen-
tial expansion effect, for example where the strip consists of 40 
laminates of materials that contract or expand differently 
from one another when exposed to a stimulus, such as heat 
(thermal expansion) or water (e.g., top layer of strip hydro-
philic while bottom layer hydrophobic). The mechanical 
means can include, for example, the linear or rotary piezo 45 
micro-motor devices described herein. As the strip 152 is 
bent, distance C increases and distance AB decreases, caus-
ing the section beyond either A or B to be stretched in a 
rectilinear manner. 
In various embodiments, the apparatus includes means for 
moving the inlet cannula, the outlet cannula, or both cannula 
to axially stretch a donor blood vessel secured between the 
inlet cannula and the outlet cannula in a submerged position 
in the tissue culture medium. The inlet cannula, the outlet 
cannula, and the donor blood vessel are secured together to 
form a conduit through which the tissue culture medium can 
flow. In one embodiment, a primer mover is operably 
connected to the inlet cannula, the outlet cannula, or both 
cannula, to axially stretch the donor blood vessel. The 
primer mover can be mechanically, electromechanically, or 
hydraulically driven. In one embodiment, either the inlet 
cannula or the outlet cannula is in a fixed position in the 
chamber, and the other cannula is moveable in a linear 
direction. The means for moving either or both of the 
cannula can include a controller for moving the cannula in 
50 a continuous or intermittent manner. 
Additionally, as balloon 160 is inflated (or the material 
expanded), the blood vessel is stretched between the two 
ends 15S and continues to stretch as the space in the channel 
defined by plates 154 is filled. Thus, the section of blood 
vessel between ends A and B is stretched in a curvilinear 
55 
manner. The two modes of stretching can occur simulta-
neously, one after another in either order, or any combina-
tion thereof. 
IV. In Vitro Operation 
Application of the Distension Devices and Methods 
The present devices and methods are useful for forming a 
vascular graft by axially stretching (i.e. distending or 
extending) a donor blood vessel to stimulate growth. This 
stretching can performed in vivo or in vitro. 
The devices and methods can be sized to stretch blood 
vessels of essentially any size and located in or excised from 
a variety of sites in the body of the patient or donor or 
60 animal. Preferred blood vessels include, but are not limited 
to, the internal mammary arteries, the gastroepipolic artery, 
the gastric artery, the radial artery, the femoral artery, and the 
splenic artery. Other arteries and veins may also be suitable 
blood vessels for use with the methods and devices. 
Currently, a short segment of blood vessel can be salvaged 
during conventional bypass surgery and an in vitro organ 
culture or bioreactor system can be used to grow sufficient 
graft tissue for a second surgery. Such surgeries represent 
about 30% of all bypass operations. The methods and 
devices described herein can be adapted to work with such 65 
surgeries, to increase the length of graft material and/or to 
reduce the required length of the salvaged segment. 
In a preferred embodiment of the in vivo distension 
method, the device is implanted, for example using endo-
scopic techniques, in the patient and vessel distension 
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effected over a period of time. Then the site of implantation 
is reexposed, all or a portion of the donor blood vessel 
section (e.g., vessel segment 62 in FIG. 3) is removed and 
the device is explanted. The ends of the donor vessel can 
then be sutured end to end to repair the donor vessel, as is 
commonly done in vascular repair without complication. 
Some blood vessels used for coronary bypass surgery, such 
as the gastroepipolic and radial arteries, can be removed 
with minimal morbidity such that repair is unnecessary. The 
removed blood vessel section is then ready for use as a graft 
in a patient in need thereof, who preferably is the same 
patient supplying the donor vessel. 
In a preferred embodiment of the in vitro distension 
method, a portion of donor blood vessel (e.g. shorter than 
that needed for a graft) is surgically excised from the patient 
in need of the graft, and then the vessel portion is stretched 
over a period of time in vitro in a medium for cell growth, 
for example, as in a bioreactor. All or a portion of the 
distended vessel is then ready for use as a graft in the patient. 
Where the donor is the recipient of the graft, the result using 
either approach advantageously is a totally autologous, 
living vascular graft. 
Preferred Embodiments 
14 
sleeve that snugly fits around the arms and stabilization rod 
may also serve as a fastener to hold the arms in a collapsed 
profile. Such a sleeve could simply be slid off of the 
stabilization rod following insertion to release the arms. The 
5 shape change of the arms 256 is preferably due to a spring 
action inherent in the material of construction of the arms 
256, such that, upon release (e.g., upon breaking of the 
connection, bond, or weld), the arms will transform from the 
straight configuration (FIG. llA) to the curved configuration 
10 (FIG. llB). Such a transformation can occur as a result of 
the elastic restorative forces normally exhibited in most 
metals and polymeric materials, forces that could be made, 
by one skilled in the art, to straighten a curved element 
formed from these materials. Nickel-titanium alloys, which 
15 exhibit super-elastic and shape-memory effects, are particu-
larly suitable. Shape memory nickel-titanium alloys and 
certain polymeric materials can be fabricated to change 
shape from straight to curved as the device warms to body 
temperature after it is inserted. Examples of shape memory 
20 polymers are described, for example, in PCT WO 99/42528 
and U.S. Pat. No. 6,160,084, which are incorporated herein. 
Methods for forming the elements of the device are well 
known to those skilled in the art. 
In a preferred embodiment of the device, the stretching 25 
mechanism is not actually attached to the blood vessel and 
FIGS. llB-llE illustrate use of the device 250 with a 
blood vessel 260 (represented as a broken line). These 
figures also illustrate the rotational movement of the rotat-
able elements 254a and 254b. First, the blood vessel 260 
should be threaded into element channels 258a and 258b of 
rotatable elements 254a and 254b, respectively, and then the 
30 rotatable elements 254a and 254b are rotated to cause the 
is therefore easier to use, as no suturing of the device to the 
vessel is required. The device also preferably is enclosed so 
that the possibility of tissue adhesions to soft tissue and/or 
infiltration by body fluids-potential problems with essen-
tially any implanted device-is minimized. The device also 
preferably includes a growth stimulating agent, such as a 
growth factor, to stimulate blood vessel tissue growth. For in 
vivo applications, the device also preferably is sized and 
shaped to facilitate minimally invasive implantation, such as 35 
by endoscopic insertion. 
Preferably, the device comprises a stretching mechanism 
which includes (i) a stabilization rod, (ii) a pair of rotatable 
elements, wherein each rotatable element is rotatably 
attached to the stabilization rod and has a channel substan-
tially perpendicular to the axis of rotation, and (iii) a means 
for rotating each rotatable element to axially distend a blood 
vessel positioned in the channels of the rotatable elements. 
vessel 260 to stretch, in a combination of rectilinear and 
curvilinear stretching. The vessel 260 is frictionally engaged 
with the rotatable elements 254 and arms 256, and need not 
be sutured or otherwise attached to the device 250. To better 
grip the blood vessel 260, the arms 256 can have a suitably 
curved cross section or groove similar to the grooves 
described in the embodiment shown in FIG. 12B. FIGS. llD 
and llE show successive rotation of rotatable elements 254a 
and 254b, as well as the associated lengthening of blood 
40 vessel 260. 
As used herein, the term "substantially perpendicular" 
includes angles between 0 and 20°, preferably between 45 
about 0 and 10°, and more preferably between 0 and 5°. 
Another variation of a preferred embodiment is shown in 
FIGS. 12A-F as device 270. The device 270 includes a 
stabilization rod 272 and two rotatable elements 274a and 
274b, which are rotatably attached to the stabilization rod 
272. The rotatable elements 274a and 274b each have a pair 
of rounded lobes extending from a central base, thereby 
One variation of such an embodiment is shown in FIGS. 
llA-E as device 250. The device 250 includes a stabiliza-
tion rod 252 and two rotatable elements 254a and 254b, 
which are rotatably attached to the stabilization rod 252. 
Rotatable elements 254a and 254b each include a pair of 
arms 256 capable of bending or flexing between a straight 
and a curved configuration, as shown by comparing FIGS. 
llA and llB. FIG. llA illustrates the device 250 in a 
collapsed form, which provides a profile that is well suited 
to endoscopic insertion. FIG. llB shows the device 250 in 
an expanded form as it would appear after insertion into the 
body but prior to use in stretching a blood vessel. The 
elements of this embodiment can be fabricated using suit-
able materials and methods to accomplish the transformation 
of shape shown. The arms 256 preferably can be maintained 
in a collapsed, straight profile (FIG. llA) with one or more 
releasable fasteners (not shown) securing the arms to one 
another or to the stabilization rod, so that the device 250 can 
providing a shape with a smooth, rounded profile to permit 
insertion with an endoscope, while not requiring the device 
to have a collapsed configuration as in device 250. FIG. 12A 
50 illustrates the device 270 in its insertion profile. FIG. 12B 
shows the device 270 in an expanded form as it would 
appear after insertion into the body, with rotatable elements 
274a and 274b rotated slightly to align channels 276a and 
276b with the stabilization rod 272, rendering the device 270 
55 ready for threading with a blood vessel 280 (represented as 
a broken line). The elements of this embodiment can be 
fabricated using suitably rigid materials and known fabri-
cation methods. Materials such as stainless steels, titanium, 
titanium alloys or biocompatible polymers are suitable. 
60 Methods for forming the elements of the device are well 
known to those skilled in the art. FIG. 12C illustrates a side 
be easily implanted. Representative examples of releasable 65 
fasteners include thin breakable connections, bonds, or 
welds, as well as screws, clamps, and hooks. A removable 
view of rotatable element 274a along line d---d in FIG. 12B. 
Rotatable elements 274a/b include grooves 278 at its periph-
ery, as shown in FIG. 12C, to support and guide the blood 
vessel 280, keeping it from slipping off of the rotatable 
elements 274a/b as the rotatable elements 274a/b rotate. 
Such grooves are optional. 
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elements from one another along the stabilization rod. For 
example, one of the rotatable elements can be a floating 
mechanism that can be moved along the stabilization rod 
away from the other, fixed, rotatable element, thus providing 
FIGS. 12B and 12D-12F illustrate use of the device 270 
with a blood vessel 280. These figures also illustrate the 
rotational movement of the rotatable elements 274a and 
274b. After blood vessel 280 is threaded into element 
channels 276a and 276b of rotatable elements 274a and 
274b, respectively, the rotatable elements 274a and 274b are 
rotated to cause the vessel 280 to stretch. More rotation will 
yield more vessel stretching, and thus a greater length of 
vessel graft material provided. 
5 additional stretch to the blood vessel segment between the 
rotatable elements. 
Yet another variation of a preferred embodiment is shown 
10 
in FIGS. 13A-E as device 290. The device 290 includes a 
stabilization rod 292 and two rotatable elements 294a and 
294b, which are rotatably attached to the stabilization rod 
292. The rotatable elements 294a and 294b are, like ele-
ments 274, shaped to have a smooth, rounded profile to 
permit insertion with an endoscope; however, elements 294 15 
are in a shape that typically should be somewhat simpler to 
manufacture. FIG. 13A illustrates device 290 in is insertion 
profile. FIG. 13B shows the device 290 in an expanded form 
as it would appear after insertion into the body, with 
rotatable elements 294a and 294b rotated slightly to align 20 
channels 296a and 296b with the stabilization rod 292, 
rendering the device 290 ready for threading with a blood 
vessel 300 (represented as a broken line). The elements of 
this embodiment also can be fabricated using suitably rigid 
materials and known fabrication methods similar to those 25 
described for the devices illustrated in FIGS. 11and12. FIG. 
13E illustrates a side view of rotatable element 294a along 
line e---e in FIG. 13B. Rotatable elements 294a/b includes 
grooves 298 at its periphery, as shown in FIG. 13E, to 
support and guide the blood vessel 300, keeping it from 
30 
slipping off of the rotatable elements 294a/b as the rotatable 
elements 294a/b rotate. 
FIG. 14 shows a variation of a rotatable element 310, 
which is provided with multiple grooves 312 for supporting 
and guiding a blood vessel. As can be seen, the grooves 312 
are in a threaded arrangement to permit multiple revolutions 35 
of the rotatable element 310, rendering a device capable of 
further increasing the length of blood vessel produced by 
stretch induced growth. 
In all of these preferred embodiments and variations, the 
stabilization rod preferably is a substantially rigid, elongated 40 
body or structure. The devices are designed so that their 
cross-sectional dimensions facilitate endoscopic implanta-
tion, preferably using available hardware. Standard trocars 
for endoscopic access range in size to 25 mm. Device length 
is influenced by choice of artery, length of graft produced, 45 
and other factors. The expected length is between about 4 cm 
and 20 cm. 
Additional means for producing the required rotational 
motion include directly driving the rotatable elements using 
suitably controlled rotary micromotors. Common mechani-
cal elements, such as racks and pinions, can be combined to 
convert linear to rotary motion. Such mechanisms can be 
driven by linear or geared rotary motors or by elastic stored 
energy, such as the energy stored in a tension or compression 
spring, or by hydraulic means or by some combination of 
these means. Activation of one or both of the rotatable 
elements, either synchronously or asynchronously, continu-
ously or intermittently, can be used as most appropriate for 
a particular embodiment. 
The methods and devices described herein optionally can 
include growth factors or other growth stimulating agents 
(e.g., hormones) to further enhance blood vessel growth. For 
example, such growth stimulating agents can be delivered to 
the blood vessel by impregnating the materials forming the 
device or by providing a suitable coating or reservoirs in the 
device that can contain and controllably release such agents 
during the extension process. Examples of growth factors 
include vascular endothelial growth factor (VEGF), endot-
helial cell growth factor (ECGF), basic fibroblast growth 
factor (bFGF), and platelet derived growth factor (PDGF). 
Biocompatible polymeric materials for controlled release 
that are known in the art for drug delivery (see e.g., U.S. Pat. 
No. 5,879,713 to Roth et al.) can be adapted for use with the 
devices described herein. The devices and methods also can 
be used in combination with external electric, magnetic, or 
electromagnetic fields applied as a growth stimulus (see e.g., 
U.S. Pat. No. 4,846,181 to Miller). 
The devices also can optionally include appropriate drugs 
(e.g., therapeutic or prophylactic agents) impregnated into or 
coated to structural components, for example to minimize 
infections, inflammatory reactions, scar tissue formation, 
adhesion formation, and/or other adverse tissue reactions. 
For example, where tissue growth is to be avoided, certain 
antifibrotic agents may be present, such as 5-fluourouracil or 
mitomycin. The device may be more generally provided 
with coatings that are antibiotic or anti-inflammatory. 
The devices also can be enclosed in a suitable sheath to 
limit adhesion formation and/or infiltration by body fluids 
while implanted in vivo, or be impregnated or coated with 
materials selected to reduce adhesion formation as known in 
the art. Examples of such coating materials include, but are 
not limited to, parylene, polytetrafluoroethylene (e.g., 
While two rotatable elements are shown and preferred, the 
device also can work with one or three or more rotatable 
elements. Additional rotatable elements can be added, by 
one skilled in the art, if needed to produce a single, more 
complex, device capable of additional lengthening. When 
such additional lengthening is necessary, it can be more 
easily achieved using multiple devices as described. 
50 TEFLON™) and chromium (e.g., ME-92™, Armoloy 
Corp.), which can be used to coat a variety of other metal 
and polymer substrates. 
The devices and methods of use thereof described herein 
are further described by the following non-limiting 
The rotational movement of the rotatable elements can be 
driven by a wide variety of forces and driver means known 
in the art. For example, the means for rotating the rotatable 
elements can include a torsion spring and a cam mechanism 
55 examples. 
for controlling the rotation position. The spring and cam 
preferably are situated within the stabilization rod. The 
rotation also may be conducted using mechanical, electro- 60 
mechanical, hydraulic, or other means known for control-
lably rotating structures relative to a base structure, for 
example, by adapting one or more of the means described 
above. In a preferred embodiment having two rotating 
elements, each rotates in opposite directions from one 65 
another. Additional (dynamic) stretching of a blood vessel 
can be achieved by variable longitudinal placement of the 
EXAMPLE 1 
In Vivo Vessel Stretching to Stimulate Cell 
Division 
Leung et al., Science 191:475-77 (1976) showed that 
cyclic stretching stimulates synthesis of matrix components 
in arterial smooth muscle cells in-vitro. Subsequent studies 
in arterial tissue have been limited to the effects stretching 
on cells attached to a membrane in cell culture (see, for 
example, Birukov, et al., Molecular & Cellular Biochem. 
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outlet cannula having a first end outside of the chamber and 
a second end positioned inside the chamber, and wherein the 
donor blood vessel is securable by having a first end of the 
vessel secured to the second end of the inlet cannula and a 
144:131-39 (1995); Costa, et al., FASEB J. 5:A1609-7191 
(1991)) or in a vascular graft construct (Kanda, et al., Cell 
Transplantation 4(6):587-95 (1995)). No known studies, 
however, have analyzed the effect of stretch on cells in intact 
vessel walls. Therefore, a study was made of porcine carotid 
arteries in an organ culture system developed by Conklin 
(Conklin, B. Viability of Porcine Common Carotid Arteries 
5 second end of the vessel secured to the second end of the 
outlet cannula, thereby forming a conduit through the blood 
vessel and between the first end of the inlet cannula and the 
in a Novel Organ Culture System MS Thesis, Georgia 
Institute of Technology, 1997), in order to determine the 
effect of axial stretching on smooth muscle cell division in 10 
an intact vessel. See also Han, H. C., Vito, R. P., Michael, K., 
Ku, D. N., "Axial Stretch Increases Cell Proliferation in 
Arteries in Organ Culture", Advances in Bioengineering, 
ASME, BED 48:63-64 (2000). 
Left and right external carotid arteries were obtained at 15 
slaughter, one for testing and the other serving as a control. 
Both vessels were immersed in cell culture media containing 
DMEM (Sigma D1152), sodium bicarbonate (3.7 g/L, 
Sigma), L-glutamine (2 mM, Sigma), antibiotic-antimycotic 
solution (10 ml/L, Gibco), and calf serum (CS 10%, Inte- 20 
gren). The vessels were perfused with the same media with 
the addition of Dextran (5% by weight, MW 282,000 
Sigma). The test and control specimen both were maintained 
at body temperature and subjected to pulsatile flow in the 
physiological range. The control specimen was restored to 25 
and maintained at the in-vivo length, which corresponds to 
a stretch ratio of 1.5, for the duration of the experiment. The 
test specimen was stretched an additional 30% to a stretch 
ratio of 1.8 over the first two and one-half days of the five 
day experiment. 30 
Bromodeoxyuridine ("BRDU") staining was used to com-
pare the number of cells that were dividing in the test and 
control specimens. On the fifth day, the specimens were 
pressure-fixed with formalin and histologic slides prepared 
for cell counting using light microscopy. The BRDU was 35 
added on day four and the test specimen showed that 
6.8+/-2.8% of the cells were dividing, while only 3.08+/ 
-2.9% of the cells were dividing in the control specimen. 
The results clearly suggest that axial stretching can be used 
to enhance cell division in blood vessels, and should there- 40 
fore be useful in the growing vessel segments for use in 
creating blood vessel grafts. 
Modifications and variations of the present invention will 
be obvious to those of skill in the art from the foregoing 
detailed description. Such modifications and variations are 45 
intended to come within the scope of the following claims. 
We claim: 
1. An apparatus for growing a donor blood vessel of a 
human or animal in vitro comprising: 
a chamber containing a tissue culture medium; 
an inlet cannula; 
an outlet cannula; and 
a means for moving the inlet cannula, the outlet cannula, 
50 
first end of the outlet cannula. 
3. The apparatus of claim 1, wherein the chamber further 
comprises one or more apertures for gas exchange with the 
tissue culture medium. 
4. The apparatus of claim 1, further comprising tissue 
culture medium flowing through the conduit. 
5. The apparatus of claim 1, wherein the means for 
moving either or both of the cannula comprises a controller 
for moving the cannula in a continuous or intermittent 
manner. 
6. The apparatus of claim 1, wherein the means for 
moving either or both of the cannula comprises a primer 
mover that is mechanically, electromechanically, or hydrau-
lically driven. 
7. The apparatus of claim 1, wherein either the inlet 
cannula or the outlet cannula is in a fixed position in the 
chamber, and the other cannula is moveable in a linear 
direction. 
8. A method of forming a vascular graft in vitro for a 
human or animal in need thereof, comprising: 
securing one end of a donor blood vessel onto an end of 
an inlet cannula and securing the other end of the donor 
blood vessel onto an end of an outlet cannula, to form 
a conduit extending through the inlet cannula, the 
donor blood vessel, and the outlet cannula; 
submerging the donor blood vessel in tissue culture 
medium; and 
moving the inlet cannula, the outlet cannula, or both, 
axially to stretch and grow the donor blood vessel 
between the first end of the inlet cannula and the first 
end of the outlet cannula, forming a length of blood 
vessel suitable as a vascular graft. 
9. The method of claim 8, further comprising flowing a 
tissue culture medium through the conduit. 
10. The method of claim 9, wherein the donor blood 
vessel is maintained at body temperature and subjected to 
pulsatile flow of tissue culture medium in a physiological 
range. 
11. The method of claim 8, wherein the donor blood 
vessel is selected from the group consisting of an internal 
mammary artery, a femoral artery, a gastroepipolic artery, a 
gastric artery, a radial artery, and a splenic artery. 
12. The method of claim 8, wherein either or both of the 
cannula are moved continuously. 
13. The method of claim 8, wherein either or both of the 
cannula are moved intermittently. 
or both, to axially stretch an excised donor blood vessel 
secured between the inlet cannula and the outlet can-
nula in a submerged position in the tissue culture 
medium, wherein the inlet cannula, the outlet cannula, 
and the donor blood vessel can be secured together to 
form a conduit through which the tissue culture 
medium can flow, 
14. The method of claim 8, wherein the donor blood 
55 vessel is submerged in tissue culture medium provided in a 
chamber comprising one or more apertures for gas exchange 
with the tissue culture medium. 
wherein the apparatus is operable to grow the donor blood 
vessel to increase its length. 
2. The apparatus of claim 1, wherein the inlet cannula 
extends through a first orifice in the chamber, the inlet 
cannula having a first end outside of the chamber and a 
second end positioned inside the chamber, wherein the outlet 
cannula extends through a second orifice in the chamber, the 
15. The method of claim 14, wherein the inlet cannula 
extends through a first orifice in the chamber, the inlet 
60 cannula having a first end outside of the chamber and a 
second end positioned inside the chamber, wherein the outlet 
cannula extends through a second orifice in the chamber, the 
outlet cannula having a first end outside of the chamber and 
a second end positioned inside the chamber, and wherein one 
65 end of the donor blood vessel is secured to the second end 
of the inlet cannula and the other end of the donor blood 
vessel is secured to the second end of the outlet cannula, 
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thereby forming a conduit through the blood vessel and 
between the first end of the inlet cannula and the first end of 
the outlet cannula. 
16. The method of claim 8, wherein the tissue culture 
medium comprises a growth factor and an antibiotic agent. s 
17. The method of claim 8, wherein the donor blood 
vessel is from a transgenic animals. 
18. The method of claim 8, wherein the donor blood 
vessel is a genetically engineered tissue. 
19. The method of claim 8, wherein the donor blood 10 
vessel is a vein from a human. 
20. An apparatus for extending a donor blood vessel of a 
human or animal in vitro comprising: 
a chamber containing a tissue culture medium; 
an inlet cannula; 
20 
an outlet cannula; and 
a primer mover operably connected to the inlet cannula, 
the outlet cannula, or both, to axially stretch an excised 
donor blood vessel secured between the inlet cannula 
and the outlet cannula in a submerged position in the 
tissue culture medium. 
21. The apparatus of claim 1, wherein the tissue culture 
medium comprises a growth factor or other growth stimu-
lating agent to enhance blood vessel growth. 
22. The method of claim 8, wherein the stretched and 
grown blood vessel has a length greater than 30% of the 
donor blood vessel. 
* * * * * 
